Trifecta Capital Advisors’s Labcorp LH Stock Holding History

Trifecta Capital Advisors’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-27	Closed	-$6.14K	–	430
2023 Q4	$6.14K	Buy	+27	New	+$5.67K	﹤0.01%	238

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Trifecta Capital Advisors's LH Position: Q1 2024 in Review

Trifecta Capital Advisors sold out of Labcorp (LH) in Q1 2024, closing a stake of 27 shares — an estimated $6.14K sold.

Trifecta Capital Advisors first reported a position in LH in Q4 2023 and held it in 1 quarter. The position peaked at $6.14K in Q4 2023. 927 funds tracked by Wall St. Rank hold LH as of Q1 2024.

Trifecta Capital Advisors reported no remaining Labcorp position as of Q1 2024 after selling out during the quarter.
Trifecta Capital Advisors sold 27 Labcorp shares in Q1 2024, an estimated $6.14K.
Trifecta Capital Advisors first reported a position in Labcorp in Q4 2023 and held it in 1 quarter.
Trifecta Capital Advisors's Labcorp position peaked at $6.14K in Q4 2023.
927 funds tracked by Wall St. Rank held Labcorp as of Q1 2024.

Based on Trifecta Capital Advisors's 13F filing for Q1 2024, filed 16 Apr 2024.